LIPid Intensive Drug therapy for Sepsis Pilot (LIPIDS-P): Phase I/II clinical trial protocol of lipid emulsion therapy for stabilising cholesterol levels in sepsis and septic shock

INTRODUCTION: Sepsis is a life-threatening, dysregulated response to infection. Both high-density lipoprotein and low-density lipoprotein cholesterol should protect against sepsis by several mechanisms; however, for partially unknown reasons, cholesterol levels become critically low in patients with...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMJ Open
Main Authors: Guirgis, Faheem W, Black, Lauren Page, Rosenthal, Martin Daniel, Henson, Morgan, Ferreira, Jason, Leeuwenburgh, Christiaan, Kalynych, Colleen, Moldawer, Lyle L, Miller, Taylor, Jones, Lisa, Crandall, Marie, Reddy, Srinivasa T, Wu, Samuel S, Moore, Frederick A
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group 2019
Assuntos:
Intensive Care
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6756323/
https://ncbi.nlm.nih.gov/pubmed/31537565
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2019-029348
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados